Lantern Pharma (LTRN)
2.84
-0.10 (3.40%)
Upcoming Events
Latest Headlines
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky
July 18, 2026 12:40 PM - StreetInsider
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group
July 11, 2026 12:30 PM - StreetInsider
Lantern Pharma launches ZetaOmics cancer bioinformatics tool
July 8, 2026 7:30 AM - StreetInsider
Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent “Computational Biologist” That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer
July 8, 2026 7:30 AM - BizWire
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
July 4, 2026 12:27 PM - StreetInsider
New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.
June 27, 2026 2:40 PM - StreetInsider
Form EFFECT Lantern Pharma Inc.
June 22, 2026 6:03 AM - SEC Filing
Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
June 12, 2026 4:39 PM - StreetInsider
Form S-1 Lantern Pharma Inc.
June 12, 2026 4:31 PM - SEC Filing
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
June 6, 2026 11:20 AM - StreetInsider
Lantern Pharma reports extended survival in lung cancer trial
June 2, 2026 8:15 AM - StreetInsider
Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer
June 2, 2026 8:13 AM - BizWire
Form 8-K Lantern Pharma Inc. For: Jun 01
June 2, 2026 6:06 AM - SEC Filing
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commoditie
May 30, 2026 11:55 AM - StreetInsider
New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, a
May 23, 2026 12:25 PM - StreetInsider
Form D Lantern Pharma Inc.
May 21, 2026 2:44 PM - SEC Filing
Lantern Pharma receives FDA clearance for HARMONIC trial amendments
May 19, 2026 7:30 AM - StreetInsider
Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never-Smokers with NSCLC
May 19, 2026 7:30 AM - BizWire
Form SCHEDULE 13D/A Lantern Pharma Inc. Filed by: Bios Equity Partners, LP
May 15, 2026 4:29 PM - SEC Filing
Form 8-K Lantern Pharma Inc. For: May 15
May 15, 2026 4:13 PM - SEC Filing
Form 10-Q Lantern Pharma Inc. For: Mar 31
May 15, 2026 4:10 PM - SEC Filing
Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates
May 15, 2026 4:01 PM - BizWire
Form 8-K Lantern Pharma Inc. For: May 12
May 14, 2026 5:27 PM - SEC Filing
Form 4 Lantern Pharma Inc. For: May 12 Filed by: Schalop Lee Troy
May 14, 2026 4:10 PM - SEC Filing
Form 4 Lantern Pharma Inc. For: May 12 Filed by: KEYSER D JEFFREY
May 14, 2026 4:10 PM - SEC Filing
Lantern Pharma closes $9.25 million registered direct offering
May 14, 2026 4:05 PM - StreetInsider
Lantern Pharma closes $9.25 million registered direct offering
May 14, 2026 4:05 PM - StreetInsider
Lantern Pharma Inc. Announces Closing of up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
May 14, 2026 4:05 PM - BizWire
Form 424B5 Lantern Pharma Inc.
May 14, 2026 9:03 AM - SEC Filing
Lantern Pharma raises up to $9.25 million in registered direct offering
May 13, 2026 8:00 AM - StreetInsider
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
May 13, 2026 8:00 AM - BizWire
Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
May 11, 2026 4:30 PM - BizWire
Lantern Pharma announces roadmap for withZeta.ai AI platform expansion
May 7, 2026 9:01 AM - StreetInsider
Lantern Pharma Unveils Roadmap for withZeta.ai — Industry-First, Multi-Agentic Co-Scientist Featuring Swarm Intelligence and Computational Biology Toolkit with the Launch of ZetaSwarm™ and ZetaOmi
May 7, 2026 9:01 AM - BizWire
Form 10-K/A Lantern Pharma Inc. For: Dec 31
April 30, 2026 6:17 AM - SEC Filing
Lantern Pharma’s predictBBB.ai Evolves Into a Real-Time Large Quantitative Model (LQM) for Precision Molecular Intelligence — Comprehensive Small Molecule Characterization & Development Analyt
April 29, 2026 8:50 AM - BizWire
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
April 25, 2026 12:55 PM - StreetInsider
CORRECTION: Join Lantern Pharma on April 30 for the First Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers
April 24, 2026 9:26 AM - StreetInsider
Join Lantern Pharma on April 30 for the First Public Demonstration of with Zeta.ai - A Platform to Conquer Rare Cancers
April 24, 2026 9:00 AM - StreetInsider
Lantern Pharma to Debut Public Demonstration of withZeta.ai - A Platform to Conquer Rare Cancers on April 30 Following AACR 2026 Scientific Debut
April 24, 2026 7:50 AM - BizWire
Full Article List
